| Drug Name: | Sotrovimab |
|---|
| Drug Class: | Monoclonal antibody |
|---|
| Mechanism of Action: | Binds to the spike protein of SARS-CoV-2, preventing viral attachment and entry into human cells |
|---|
| Use: | - Treatment of mild to moderate COVID-19 in high-risk individuals
- Prevention of COVID-19 in individuals at high risk of exposure
|
|---|
| Side Effects: | - Headache
- Fatigue
- Nausea
- Diarrhea
- Allergic reactions (rare)
|
|---|
| Contraindications: | - Hypersensitivity to sotrovimab or any component of the formulation
|
|---|
| Specialty: | - Infectious Disease
- Pulmonology
- Internal Medicine
|
|---|